
BioCer is attending in the WCES 2025
BioCer is proud to be attending in the World Congress of Endoscopic Surgery (WCES) for the first time in 2025. This prestigious event, considered the world’s leading congress in the field of minimally invasive surgery, will take place from 4-8 November at the Suntec Convention & Exhibition Centre in Singapore and will bring together experts, surgeons and medical technology companies from around the world.
Minimally invasive surgery solutions
Our booth offers an ideal platform for presenting BioCer’s innovative solutions. The focus is on our product range for minimally invasive procedures, including hemostats and suture protection solutions that are characterised by the highest quality, safety and user-friendliness. These products enable more efficient and safer operations – a decisive advance for modern surgery.
The WCES also offers us the opportunity to actively exchange ideas with leading specialists and decision-makers. With exciting lectures, workshops and live demonstrations, the congress is a valuable source of information on current trends and technological innovations. BioCer aims to use this knowledge to further develop its own products and make an important contribution to the future of minimally invasive surgery.
Participation in the WCES 2025 marks an important step in the internationalisation of BioCer. In addition to product presentation, establishing new partnerships is a central component of our presence at the trade fair.
We warmly invite all congress visitors to visit our stand, see the quality of our products for themselves and discuss the future of minimally invasive surgery with us.
Overview of the event details:
Location: Suntec Convention & Exhibition Centre, Singapore
Date: 4–8 November 2025
Topics: Minimally invasive surgery, haemostatic agents, innovations in medical technology
The complete programme and further information can be found on the official website: wces2025.com.